Your browser is no longer supported. Please, upgrade your browser.
Settings
PTIE Pain Therapeutics, Inc. daily Stock Chart
PTIE [NASD]
Pain Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.98 Insider Own21.99% Shs Outstand6.41M Perf Week4.49%
Market Cap28.33M Forward P/E- EPS next Y-2.90 Insider Trans0.00% Shs Float5.15M Perf Month13.62%
Income-12.90M PEG- EPS next Q- Inst Own36.90% Short Float13.33% Perf Quarter20.44%
Sales- P/S- EPS this Y-5.30% Inst Trans143.20% Short Ratio16.79 Perf Half Y-21.59%
Book/sh2.03 P/B2.18 EPS next Y-23.40% ROA-70.30% Target Price23.75 Perf Year-13.48%
Cash/sh2.20 P/C2.01 EPS next 5Y- ROE-75.10% 52W Range3.10 - 9.31 Perf YTD10.74%
Dividend- P/FCF- EPS past 5Y-40.60% ROI- 52W High-52.52% Beta2.18
Dividend %- Quick Ratio14.10 Sales past 5Y- Gross Margin- 52W Low42.58% ATR0.24
Employees9 Current Ratio14.10 Sales Q/Q- Oper. Margin- RSI (14)59.49 Volatility8.67% 5.35%
OptionableYes Debt/Eq0.00 EPS Q/Q-37.80% Profit Margin- Rel Volume1.33 Prev Close4.59
ShortableYes LT Debt/Eq0.00 EarningsNov 08 BMO Payout- Avg Volume40.86K Price4.42
Recom4.00 SMA204.31% SMA5020.09% SMA2003.33% Volume54,345 Change-3.70%
Jul-17-17Downgrade Gabelli & Co Hold → Sell
Sep-13-16Downgrade Gabelli & Co Buy → Hold $2.50
Aug-17-12Initiated C.K. Cooper Buy $12
Apr-17-09Upgrade Credit Suisse Underperform → Neutral
Mar-28-08Initiated Punk, Ziegel & Co Buy $11
Feb-28-08Initiated Credit Suisse Underperform $7
Feb-08-08Upgrade Broadpoint Capital Underperform → Neutral
Dec-21-07Initiated Broadpoint Capital Underperform $8.85
May-03-07Downgrade Needham & Co Buy → Hold
Oct-05-17 09:25PM  How Should You Think About Pain Therapeutics Incs (PTIE) Risks? Simply Wall St.
Sep-18-17 07:00AM  NIH Awards $1.8 Million Research Grant to Pain Therapeutics in Support of a Blood-based Diagnostic for Alzheimers Disease GlobeNewswire +9.25%
07:00AM  National Institute on Drug Abuse Awards Pain Therapeutics $2.2 Million Grant GlobeNewswire
Aug-10-17 12:33AM  Pain Therapeutics reports 2Q loss Associated Press
Aug-09-17 08:00AM  Pain Therapeutics Reports Q2 2017 Financial Results And Mid-year Corporate Update GlobeNewswire
Jul-31-17 08:00AM  Pain Therapeutics Announces FDA Has Cleared an Investigational New Drug (IND) Application for PTI-125 GlobeNewswire
Jun-05-17 09:00AM  NIH Awards $1.7 Million Research Grant to Pain Therapeutics to Study Alzheimers Disease GlobeNewswire
Jun-01-17 09:00AM  Pain Therapeutics Announces Research Publication on Alzheimers Disease GlobeNewswire
May-08-17 09:14AM  Pain Therapeutics Announces Reverse Stock Split GlobeNewswire -23.51%
Apr-25-17 05:51PM  Pain Therapeutics reports 1Q loss Associated Press
05:47PM  Pain Therapeutics Reports First Quarter 2017 Financial Results GlobeNewswire
Mar-21-17 06:06AM  PAIN THERAPEUTICS INC Files SEC form 8-K, Other Events +45.59%
05:17AM  Pain Therapeutics Remoxy ER Secures FDA Regulatory Guidance (PTIE,EGLT) Investopedia
05:17AM  Pain Therapeutics Remoxy ER Secures FDA Regulatory Guidance (PTIE,EGLT) at Investopedia
Mar-20-17 06:59PM  Pain Therapeutics Announces Positive Regulatory Guidance for REMOXY ER GlobeNewswire
Mar-11-17 01:04PM  PAIN THERAPEUTICS INC Financials
Mar-07-17 04:31PM  PAIN THERAPEUTICS INC Files SEC form 10-K, Annual Report
Feb-21-17 11:11AM  Heres What The Latest Pain Therapeutics, Inc. (PTIE) Update Means Insider Monkey
11:11AM  Heres What The Latest Pain Therapeutics, Inc. (PTIE) Update Means at Insider Monkey
Feb-17-17 09:26AM  Pain Therapeutics reports 4Q loss Associated Press
09:02AM  PAIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
09:00AM  Pain Therapeutics Reports 2016 Financial Results GlobeNewswire
Dec-16-16 07:54PM  Pain Therapeutics, Inc. (PTIE): How Does It Compare Against Its Peers? Insider Monkey
07:54PM  Pain Therapeutics, Inc. (PTIE): How Does It Compare Against Its Peers? at Insider Monkey
Dec-11-16 08:00AM  Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Pain Therapeutics, Inc. Class Action and Settlement Hearing PTIE GlobeNewswire
Dec-08-16 04:31PM  PAIN THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events +5.16%
Nov-18-16 04:15PM  PAIN THERAPEUTICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand
Nov-11-16 08:00AM  Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Pain Therapeutics, Inc. Class Action and Settlement Hearing PTIE GlobeNewswire
Nov-01-16 03:00PM  Durect (DRRX) Exited Third Quarter with Strong Balance Sheet Zacks Small Cap Research
Oct-26-16 06:02AM  PAIN THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
Oct-20-16 09:27AM  Pain Therapeutics reports 3Q loss
09:01AM  PAIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition
09:00AM  Pain Therapeutics Reports Q3 2016 Financial Results GlobeNewswire
Oct-11-16 09:13AM  Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Pain Therapeutics, Inc. Class Action and Settlement Hearing - PTIE PR Newswire
Oct-01-16 08:00AM  Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Pain Therapeutics, Inc. Class Action and Settlement Hearing PTIE GlobeNewswire
Sep-29-16 09:44AM  Pain Therapeutics (PTIE) Enters Oversold Territory Zacks -10.62%
Sep-28-16 10:52AM  Pain Therapeutics (PTIE) Down on CRL for Chronic Pain Drug Zacks -5.04%
Sep-27-16 04:04PM  Austin drugmaker's stock falters after latest FDA rejection at bizjournals.com -10.53%
Sep-26-16 03:21PM  Durect Corp. (DRRX) Stock Tumbles on FDA Opioid Analgesic Drug Rejection -51.28%
01:35PM  5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy
01:21PM  GW Pharmaceuticals (GWPH), Sally Beauty Holdings Inc. (SBH) & More: Why These Stocks Are Making Monster Moves at Insider Monkey
11:41AM  For Pain Therapeutics CEO, 3 FDA Rejections Are Worth $23 Million
09:50AM  Is Pain Therapeutics an Incredible Momentum Stock? 3 Reasons Why PTIE Will Be Tough to Beat
07:55AM  Get ready. One of techs biggest darlings is in for a bumpy ride at MarketWatch
07:20AM  Pain Therapeutics receives FDA letter saying NDA for opioid analgesic can't be approved at MarketWatch
07:05AM  DURECT's Licensee Pain Therapeutics Receives Complete Response Letter from FDA for REMOXY® ER (oxycodone) Extended-Release Capsules CII PR Newswire
07:01AM  PAIN THERAPEUTICS INC Files SEC form 8-K, Other Events
07:00AM  Complete Response Letter for REMOXY® GlobeNewswire
Sep-23-16 10:35AM  Will Pain Therapeutics (PTIE) Continue to Surge Higher?
Sep-13-16 09:26AM  Pain Therapeutics downgraded by Gabelli & Co -5.47%
Jul-22-16 08:45AM  Pain Therapeutics (PTIE) Worth a Look: Stock Gains 7.6%
Jul-19-16 05:07PM  Pain Therapeutics reports 2Q loss
04:31PM  PAIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition
04:30PM  Pain Therapeutics Reports Q2 2016 Financial Results GlobeNewswire
Jul-12-16 09:00AM  Top 3 Biotech Companies Awaiting FDA Approval at Investopedia
Jul-05-16 12:27PM  Is Pain Therapeutics, Inc. (PTIE) And Remoxys Long And Winding Road Nearing An End? at Insider Monkey
Jul-01-16 09:05AM  DURECT Provides REMOXY® Update PR Newswire
09:00AM  Pain Therapeutics Announces Advisory Committee Meeting for REMOXY® Is Not Needed GlobeNewswire
Jun-29-16 04:11PM  PAIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
Jun-08-16 06:05PM  Pain Therapeutics, Inc. :PTIE-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016
May-19-16 09:05AM  DURECT Announces FDA Advisory Committee Meeting for REMOXY® PR Newswire
09:00AM  Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY® GlobeNewswire
May-12-16 04:48PM  PAIN THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-11-16 09:05AM  Pain Therapeutics to Present New REMOXY Data At American Pain Society Meeting GlobeNewswire
09:05AM  DURECT Announces New REMOXY® Data being Presented at American Pain Society Meeting PR Newswire
May-06-16 11:50AM  DRRX: Update on First Quarter Financials
May-05-16 07:01PM  Pain Therapeutics reports 1Q loss
04:10PM  PAIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
04:05PM  Pain Therapeutics Reports Q1 2016 Financial Results GlobeNewswire
Apr-13-16 11:32AM  Pain Therapeutics Gains 7%, FDA Has Accepted Company's Remoxy For Review +7.14%
Apr-12-16 06:34PM  DURECT Announces FDA Acceptance of REMOXY® NDA, PDUFA Date of September 25, 2016 PR Newswire
04:16PM  PAIN THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:05PM  FDA Accepts REMOXY NDA for Review, Sets PDUFA Date of September 25, 2016 GlobeNewswire
Mar-30-16 11:20AM  DRRX: REMOXY® NDA Resubmitted
Mar-29-16 11:15AM  DURECT Announces Resubmission of REMOXY® New Drug Application to the U.S. Food and Drug Administration PR Newswire
08:17AM  Pain Therapeutics Resubmits REMOXY New Drug Application to the U.S. Food and Drug Administration at noodls
08:06AM  PAIN THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  Pain Therapeutics Resubmits REMOXY New Drug Application to the U.S. Food and Drug Administration GlobeNewswire
Mar-15-16 10:20AM  Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids at 24/7 Wall St.
Mar-03-16 06:09AM  PAIN THERAPEUTICS INC Files SEC form 10-K, Annual Report
Mar-01-16 08:02AM  PAIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh +9.24%
08:00AM  Pain Therapeutics Reports 2015 Financial Results and Corporate Update GlobeNewswire
Dec-22-15 06:03AM  PAIN THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibi
Dec-02-15 08:25AM  Equities Driven By Market Influences - Research on Huttig Building Products, Pain Therapeutics, Dixie Group and Cerulean Pharma Accesswire
Nov-27-15 09:26AM  Is The McClatchy Company (MNI) A Good Stock To Buy? at Insider Monkey
Nov-24-15 06:23AM  Hedge Funds Are Abandoing Pain Therapeutics, Inc. (PTIE) at Insider Monkey
Nov-10-15 06:04AM  PAIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition
Nov-09-15 06:35PM  PAIN THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
05:49PM  Pain Therapeutics reports 3Q loss
05:43PM  Pain Therapeutics Reports Q3 2015 Financial Results and Update on REMOXY GlobeNewswire
Sep-21-15 08:00AM  NIH Awards $1.7 Million Innovation Grant to Pain Therapeutics GlobeNewswire
Sep-08-15 03:15PM  DRRX: Update on Second Quarter 2015 Financials
Jul-25-15 08:09PM  10-Q for Pain Therapeutics, Inc. at Company Spotlight
Jul-23-15 08:24AM  Pain Therapeutics reports 2Q loss
08:01AM  PAIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition
08:00AM  Pain Therapeutics Reports Q2 2015 Financial Results GlobeNewswire
Jul-09-15 04:58PM  PAIN THERAPEUTICS INC Files SEC form 8-K, Other Events
Jun-29-15 05:07PM  PAIN THERAPEUTICS INC Files SEC form 8-K, Other Events
Jun-24-15 01:53PM  Cantor Analyst: Durect Is Worth $3/Share, So Buy It
Jun-11-15 04:19PM  PAIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
Pain Therapeutics, Inc., a biopharmaceutical company, develops drugs for treating nervous system in the United States. The company's lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone for pain relief. It also develops FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; and PTI-125, a small molecule drug candidate to treat Alzheimer's disease and other neurological disorders. The company was founded in 1998 and is based in Austin, Texas.